CMExpress

Clinical Roundtable Monograph: The Future Use of Combination Therapies to Avoid Viral Resistance and Achieve Sustained Response in Chronic Hepatitis C

Ira M. Jacobson, MD, John G. McHutchison, MD, and Mark Sulkowski, MD

Volume 3, Issue 12 , Supplement 34

The morbidity and mortality associated with chronic hepatitis C infection has been dramatically alleviated with the introduction of the current standard of therapy, pegylated interferon in combination with ribavirin. However, a significant number of infected patients do not respond adequately to treatment, or are unable to receive this therapy due to adverse effects. An increased understanding of the biology of the hepatitis C virus has helped to further the discovery and clinical development of a novel class of targeted antiviral agents with activity against hepatitis C–specific proteins. Recent studies have focused on the mutational resistance the hepatitis C virus displays against these new agents. The main strategy to overcome this resistance is combination therapy, a modality that has become the focus and future goal of therapy to achieve a sustained virologic response in patients with chronic hepatitis C.

Download PDF

Visit CME University to take test

Doctor reading.

How It Works

To complete the post-test online:

  1. Access the lesson by clicking Download PDF.
  2. Click on the CME University link. You will need to register before you can access the electronic post-test.
    (If you are not automatically directed to the post-test, go to the navigation menu, and search by Lesson ID #)
  3. Upon successfully completing the post-test and evaluation, your certificate will be made available immediately.

If any of the lessons shown at right do not contain a CME University link, simply download and read that lesson, and follow the instructions on the post-test page for obtaining CME credit.